Evolution of Translational Omics: Lessons Learned and the Path Forward (2012)
Chapter: Acronyms and Abbreviations
Visit
NAP.edu/10766
to get more information about this book, to buy it in print, or to
download it as a free PDF.
Previous Chapter:
Appendix F: Information Gathering Sessionsand Speakers
Next Chapter: Glossary
Suggested Citation:
"Acronyms and Abbreviations." Institute of Medicine. 2012. Evolution of Translational Omics: Lessons Learned and the Path Forward. Washington, DC: The National Academies Press.
doi: 10.17226/13297.
| ACR | acute cellular rejection | |
| AHRQ | Agency for Healthcare Research and Quality | |
| ALK | anaplastic lymphoma kinase | |
| ASCO | American Society of Clinical Oncology | |
| BCBS | Blue Cross Blue Shield | |
| CAD | coronary artery disease | |
| CAP | College of American Pathologists | |
| CARGO | Cardiac Allograft Rejection Gene Expression Observational | |
| CDC | Centers for Disease Control and Prevention | |
| CI | confidence interval | |
| CLIA | Clinical Laboratory Improvement Amendments of 1988 | |
| CMF | cyclophosphamide, methotrexate, and fluorouracil | |
| CMS | Centers for Medicare & Medicaid Services | |
| CMV | cytomegalovirus | |
| COI | conflict of interest | |
| CONSORT | Consolidated Standards of Reporting Trials | |
| CPRC | Cancer Center Protocol Review Committee | |
| CTAF | California Technology Assessment Forum | |
| CTMS | clinical trial management systems | |
| CTSA | Clinical Translational Science Award | |
| dbGaP | database of Genotypes and Phenotypes | |
| DNA | deoxyribonucleic acid |
Suggested Citation:
"Acronyms and Abbreviations." Institute of Medicine. 2012. Evolution of Translational Omics: Lessons Learned and the Path Forward. Washington, DC: The National Academies Press.
doi: 10.17226/13297.
| DOD | Department of Defense | |
| DSMB | data safety monitoring board | |
| EGAPP | Evaluation of Genomic Applications in Practice and Prevention | |
| EMB | endomyocardial biopsy | |
| EQUATOR | Enhancing the QUAlity and Transparency Of health Research | |
| FDA | Food and Drug Administration | |
| FFATA | Federal Funding Accountability and Transparency Act | |
| FFPE | formalin-fixed, paraffin-embedded | |
| FISH | fluorescence in situ hybridization | |
| HER2 | human epidermal growth factor receptor 2 | |
| HHS | U.S. Department of Health and Human Services | |
| HPV | human papillomavirus | |
| HR | hazard ratio | |
| ICMJE | International Committee of Medical Journal Editors | |
| IDE | investigational device exemption | |
| IDMC | independent data monitoring committee | |
| IHC | immunohistochemistry | |
| IMAGE | Invasive Monitoring Attenuation through Gene Expression | |
| IND | investigational new drug | |
| IOM | Institute of Medicine | |
| IOTF | Interagency Oncology Task Force | |
| IRB | Institutional Review Board | |
| ISHLT | International Society for Heart and Lung Transplantation | |
| ISO | International Organization for Standardization | |
| IVD | in vitro diagnostic | |
| IVDMIA | in vitro diagnostic multivariate index assay | |
| LDT | laboratory-developed test | |
| LMS | Lung Metagene Score | |
| MALDI | matrix-assisted laser desorption/ionization | |
| MALDI-TOF | time-of-flight mass spectrometer | |
| MF | methotrexate and fluorouracil | |
| MIAME | Minimum Information About a Microarray Experiment | |
| MIBBI | Minimum Information for Biological and Biomedical Investigations |
Suggested Citation:
"Acronyms and Abbreviations." Institute of Medicine. 2012. Evolution of Translational Omics: Lessons Learned and the Path Forward. Washington, DC: The National Academies Press.
doi: 10.17226/13297.
| MINDACT | Microarray In Node negative and 1-3 positive lymph node Disease may Avoid ChemoTherapy | |
| miRNA | micro RNA | |
| MoS | Manual of Style: A Guide for Authors and Editors | |
| MRI | magnetic resonance imaging | |
| mRNA | messenger RNA | |
| MS | mass spectrometry | |
| NAS | National Academy of Sciences | |
| NCCN | National Comprehensive Cancer Network | |
| NCI | National Cancer Institute | |
| ncRNA | non-coding RNA | |
| NIH | National Institutes of Health | |
| NIST | National Institute of Standards and Technology | |
| NMR | nuclear magnetic resonance | |
| NOCEDP | National Ovarian Cancer Early Detection Program | |
| NRC | National Research Council | |
| NSABP | National Surgical Adjuvant Breast and Bowel Project | |
| OHRP | Office of Human Research Protections | |
| ORI | Office of Research Integrity | |
| PBMC | peripheral blood mononuclear cells | |
| PHS | Public Health Service | |
| PI | principal investigator | |
| PMA | premarket approval | |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses | |
| PSA | prostate-specific antigen | |
| QMS | quality management systems | |
| qRT-PCR | quantitative reverse-transcriptase polymerase chain reaction | |
| RCT | randomized controlled trial | |
| REMARK | REporting recommendations for tumor MARKer prognostic studies | |
| RNA | ribonucleic acid | |
| RNAseq | RNA sequencing | |
| rRNA | ribosomal RNA | |
| RS | Recurrence Score | |
| RT-PCR | reverse-transcriptase polymerase chain reaction | |
| RxPONDER | Rx for POsitive NoDe, Endocrine Responsive breast cancer |
Suggested Citation:
"Acronyms and Abbreviations." Institute of Medicine. 2012. Evolution of Translational Omics: Lessons Learned and the Path Forward. Washington, DC: The National Academies Press.
doi: 10.17226/13297.
| SELDI | surface-enhanced laser desorption/ionization | |
| SELDI-TOF | SELDI time-of-flight mass spectrometer | |
| SERMs | selective estrogen receptor modulators | |
| SGO | Society of Gynecologic Oncology | |
| SNP | single nucleotide polymorphism | |
| SOP | standard operating procedure | |
| SPCI | Simone Protective Cancer Institute | |
| SQUIRE | Standards for QUality Improvement Reporting Excellenc | |
| SRM | selected reaction monitoring | |
| SS | similarity score | |
| STARD | STAndards for the Reporting of Diagnostic accuracy studies | |
| STROBE | STrengthening the Reporting of OBservational studies in Epidemiology | |
| TAILORx | Trial Assigning IndividuaLized Options for Treatment | |
| TEC | Blue Cross Blue Shield Technology Evaluation Center | |
| TMQF | Translational Medicine Quality Framework | |
| tRNA | transfer RNA | |
| USPSTF | U.S. Preventive Services Task Force |
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.